Pancreatic Cancer Research

ResearcherEmory UniversityNo recent work listed

Liya Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0317-5685; OpenAlex author ID A5101804481. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 2

  1. Actively targeted delivery of SN38 by ultrafine iron oxide nanoparticle for treating pancreatic cancer. Last author DOI 10.1007/s10637-022-01231-9↗
  2. IGF1 Receptor Targeted Theranostic Nanoparticles for Targeted and Image-Guided Therapy of Pancreatic Cancer. Co-author DOI 10.1021/acsnano.5b01288↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ting Xue · 1 shared paper, 2022 · strength 0.17
  2. Hui Mao · 1 shared paper, 2015 · strength 0.05
  3. Hongyu Zhou · 1 shared paper, 2015 · strength 0.05
  4. David A. Kooby · 1 shared paper, 2015 · strength 0.05
  5. Lily Yang · 1 shared paper, 2015 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.